News & events

Press Releases

On the 28th March 2022, OncoArendi changed its name to Molecure

Invitation to tender

6 March 2014

OncoArendi Therapeutics has signed an exclusive agreement

30 January 2014

OncoArendi Therapeutics has closed its angel investment round raising

21 January 2014

OncoArendi has signed a contract agreement with the Polish Agency for Enterprise Development

5 November 2013

The Nencki Institute of Experimental Biology has just signed

6 June 2013

A patent application for the OAT-449

9 April 2013

Events & Presentations

EFMC – International Symposium on Medicinal Chemistry – Ljubljana 02-06.09.2018

17 September 2018

ERS International Congress 2018 – Paris, France 15-19.09.2018

14 September 2018

54th International Conference on Medicinal Chemistry, Strasbourg, France – July 4-6, 2018.

17 July 2018

ATS 2018, 18 – 23 May, San Diego, USA

21 May 2018

ESMO Immuno Oncology Congress Geneva – December 7-10

1 December 2017

AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, October 26 – 30, 2017

1 October 2017